Explore our materials

Andean Pacific Workshop on HIV & Hepatitis 2017

Proviral DNA as a Target for HIV-1 Resistance Analysis- Dr. Lara

Mauro Schechter

MD, PhD

Andean Pacific Workshop on HIV & Hepatitis 2017

State-of-the-art lecture on PrEP- Mauro Schechter, MD, PhD

Charles Boucher

MD, PhD

Andean Pacific Workshop on HIV & Hepatitis 2017

New approaches for preventing transmission- Charles Boucher, MD, PhD

APCdlT

Ana Paulina Celi de la Torre

Andean Pacific Workshop on HIV & Hepatitis 2017

Difficult to reach populations in Latin America- Ana Paulina Celi de la Torre, MD

Marcelo Wolff

MD, FACP, FIDSA

Andean Pacific Workshop on HIV & Hepatitis 2017

HIV in Latin America: 35 years later- Marcelo Wolff, MD, FACP, FIDSA

Alejandro Afani

Andean Pacific Workshop on HIV & Hepatitis 2017

WHO Target 90-90-90 : Achievable for Latin America- Alejandro Afani, MD

Ricardo Diaz

Andean Pacific Workshop on HIV & Hepatitis 2017

HIV cure and eradication | Ricardo Diaz, MD

Carlos Beltrán

Andean Pacific Workshop on HIV & Hepatitis 2017

Present and future of ART in Latin America | Carlos Beltrán, MD

Mark Nelson

MD, MBBS, FRCP

Andean Pacific Workshop on HIV & Hepatitis 2017

Do we really need new drugs? | Mark Nelson, MD

EMB

Ernesto Martinez Buitrago

Andean Pacific Workshop on HIV & Hepatitis 2017

The aging HIV infected patient - neurological issues - poly pharmacy | Ernesto Martinez Buitrago, MD

Isabel Cassetti

Andean Pacific Workshop on HIV & Hepatitis 2017

HIV in Women - PTMCT - pregnancy | Isabel Cassetti, MD

Francesca Ceccherini-Silberstein

PhD